Age: 34.0
Sex: M
Vaccine: HPV4
Symptoms: Blood aluminium increased, Confusional state, Dizziness, Dyspnoea, Flatulence
Clinical narrative: low libido; heart arrythmia; autonomic, autoimmune, and neurological injuries; autonomic, autoimmune, and neurological injuries; autonomic, autoimmune, and neurological injuries; paresthesia; high level of aluminium in his blood; experienced insomnia and the amount of sleep ranged from 4-5 hours per night; confused; night sweats, pool of sweat; high blood pressure/hypertension/experienced shortness of breath/headaches; loss of balance/Dizzy; tremors; tinnitus; Irritable bowel syndrome: stomach problems after eating, painful bloating and gas; numbness of limbs; Information has been received regarding a case in litigation from a lawyer concerning an adult male patient (pt). The pt's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions, or allergies were not reported. On 01-OCT-2020, at the age of 34 years old, he was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (dose, strength, vaccination scheme, route of administration, anatomical location lot number and expiration date were not provided), administered for preventing cervical cancer, it was reported as the only dose he received. On approximately 29-OCT-2020 (also reported as 4 weeks after the vaccination with the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)), the pt woke up in the middle of the night with a pool of sweat, dizzy, confused and shortness of breath. Later, on an unknown date in 2020 (also reported as "a few days later"), he began with stomach problems after eating, painful bloating and gas. On an unspecified day in November 2020, when these symptoms began to worsen, he went to the emergency room and was diagnosed with irritable bowel syndrome (IBS). On an unknown date in 2020 (reported as "the following weeks"), he experienced tinnitus, tremors and numbness of the limbs. On an unspecified day in October 2021, the pt experienced insomnia and the amount of sleep ranged from 4-5 hours per night. Then, on an unknown day in November 2021, pt experienced paresthesia and a bloodwork indicated that he had high level of aluminum in his blood. Moreover, as the months progressed, so did his injuries, as on unspecified dates, he was seen by multiple physicians for his complains which included low libido, heart arrythmia, headaches, high blood pressure and hypertension and loss of balance. Likewise, the pt sustained serious autoimmune, autonomic, and neurological injuries as a result. As a result of his post- quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, he had been unable to engage in activities that a normal young person would enjoy, as pt had not been able to start a family. Based upon his chronic and severe post- quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt had been diagnosed with various medical conditions, including but not limited to, irritable bowel syndrome (IBS), heart arrythmia, night sweats, headaches, high blood pressure, insomnia, tinnitus, loss of balance and hypertension. As a proximate result of company's wrongful acts and omissions and its negligent and fraudulent testing, labeling, manufacturing, marketing and promotion of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), the pt had suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and had suffered severe and permanent physical injuries, including pain and suffering, he also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with his injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of his quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and he will continue to incur these losses and expenses in the future. At the time of reporting, the pt had not recovered from the events. The reporter considered all the aforementioned events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  All the events were considered disabling by the reporter.   Upon internal review, the events autoimmune disorder and arrhythmia were determined to be medically significant.